Call for papers - Nanomedicine

Guest Editor

Koushik Debnath, PhD, University of Illinois Chicago, USA

Submission Status: Open | Submission Deadline: 19 December 2025

BMC Pharmacology and Toxicology is calling for submissions to our Collection on Nanomedicine. This Collection invites contributions that explore the dynamic field of nanomedicine, focusing on the application of nanoparticles, dendrimers, and nanocarriers in drug delivery and therapy. We welcome research that investigates the efficacy, safety, and innovative uses of nanomedicine, aiming to advance our understanding of its potential to transform healthcare and improve patient outcomes.

New Content Item This Collection supports and amplifies research related to SDG 3: Good Health and Well-Being.

Submit to Collection

Meet the Guest Editor

Back to top

Koushik Debnath, PhD, University of Illinois Chicago, USA

Dr Koushik Debnath is a bio-materials scientist at the University of Illinois Chicago, specializing in the design of Nanomedicine for tissue regeneration. His research focuses on the development of nanomedicine for the treatment of neurodegenerative diseases. Additionally, he explores the utilization of cell-secreted extracellular vesicles for targeted cargo delivery in the context of degenerative diseases.

About the Collection

BMC Pharmacology and Toxicology is calling for submissions to our Collection on Nanomedicine.

Nanomedicine has emerged as a transformative field at the intersection of nanotechnology and medicine, highlighting in diagnosis, treatment, and prevention of diseases. The nanomedicine utilizes human-generated materials and devices that are thousands of times smaller than the diameter of a human hair and can work with human body at the atomic or molecular level to improve target specific and overall efficacy but limiting side effect of drugs compared to traditional therapies. This therapeutic strategy has opened new avenues for treating complex diseases, including cancers, neurological disorders, and infectious diseases, marking a pivotal shift in personalized medicine and therapeutic interventions.

As research in nanomedicine continues to expand, we can anticipate groundbreaking advancements that will further refine drug delivery systems and enhance therapeutic outcomes. Future innovations may include the development of smart nanocarriers capable of responding to specific biological stimuli, thereby improving the precision of drug release. Moreover, ongoing studies may lead to more comprehensive assessments of the long-term safety and efficacy of nanomedicines, ultimately contributing to a more robust understanding of their role in modern healthcare.

Our Collection welcomes research articles focusing on, but not limited to, the following aspects:

Advances and potential medical application of nanotechnology
Evaluation and prediction of adverse reaction and efficacy of nanotechnology in therapeutic treatment
Development and improvement of nanotechnology-based drug delivery or efficacy system
Nanomedicine in gene therapy
Innovative diagnosis and implanted nanodevices and their clinical application

This Collection supports and amplifies research related to SDG 3: Good Health and Well-Being.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

There are currently no articles in this collection.

Submission Guidelines

Back to top

This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Nanomedicine" from the dropdown menu.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.